{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:08:20Z","timestamp":1791875300475,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jconrel.2021.10.031","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T12:06:19Z","timestamp":1635941179000},"page":"616-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery"],"prefix":"10.1016","volume":"341","author":[{"given":"Kelsey L.","family":"Swingle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav K.","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Palanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeksha","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savan K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningqiang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Gabriel","family":"Alameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Peranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.10.031_bb0005","series-title":"Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders","author":"Yang","year":"2013"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(18)31940-8","article-title":"Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study","volume":"393","author":"Lord","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis","volume":"62","author":"Lo","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ymthe.2018.01.006","article-title":"G6PC mRNA therapy positively regulates fasting blood glucose and decreases liver abnormalities in a mouse model of glycogen storage disease 1a","volume":"26","author":"Roseman","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav8375","article-title":"In utero gene editing for monogenic lung disease","volume":"11","author":"Alapati","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0030","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1038\/s41467-018-04894-2","article-title":"In utero nanoparticle delivery for site-specific genome editing","volume":"9","author":"Ricciardi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2020.11.002","article-title":"Delivery technologies for in utero gene therapy","volume":"169","author":"Palanki","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0040","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1038\/mtm.2016.20","article-title":"In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application","volume":"5","author":"Almeida-Porada","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40291-020-00445-y","article-title":"The future of in utero gene therapy","volume":"24","author":"Peranteau","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0050","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/d41586-018-07643-z","article-title":"Prenatal gene therapy offers the earliest possible cure","volume":"564","author":"DeWeerdt","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0055","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ymthe.2018.12.012","article-title":"Delivery of mRNA therapeutics for the treatment of hepatic diseases","volume":"27","author":"Trepotec","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8247935","article-title":"SERPINA1 mRNA as a treatment for alpha-1 antitrypsin deficiency","volume":"2018","author":"Connolly","year":"2018","journal-title":"J. Nucleic Acids."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0065","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41591-018-0184-6","article-title":"In utero CRISPR-mediated therapeutic editing of metabolic genes","volume":"24","author":"Rossidis","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/jgm.421","article-title":"Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice","volume":"5","author":"Bouchard","year":"2003","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0075","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/mt.2010.125","article-title":"Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector","volume":"18","author":"Stitelman","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.mt.6300332","article-title":"Efficient in vivo targeting of epidermal stem cells by early gestational Intraamniotic injection of lentiviral vector driven by the keratin 5 promoter","volume":"16","author":"Endo","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/mthe.2001.0428","article-title":"In utero AAV-mediated gene transfer to rabbit pulmonary epithelium","volume":"4","author":"Boyle","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000071984","article-title":"Percutaneous ultrasound-guided injection of the Trachea in fetal sheep: a novel technique to target the fetal airways","volume":"18","author":"David","year":"2003","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0095","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-018-0106-7","article-title":"Fetal gene therapy for neurodegenerative disease of infants","volume":"24","author":"G","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0105","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nbt0918-777","article-title":"Alnylam launches era of RNAi drugs","volume":"36","author":"Garber","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0135","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 \u2014 preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0140","first-page":"1","article-title":"Immunogenic BNT162b vaccines protect rhesus macaques from SARS-CoV-2","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0155","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","article-title":"Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA","volume":"17","author":"Patel","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0165","doi-asserted-by":"crossref","first-page":"1805308","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer-based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I","volume":"30","author":"Cheng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","volume":"7","author":"Riley","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0175","first-page":"9","article-title":"Lipid nanoparticle formulations for enhanced co-delivery of siRNA and mRNA","author":"Ball","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0185","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1039\/C8NR09855G","article-title":"The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles","volume":"11","author":"Chen","year":"2019","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0190","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular Corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11051-010-0022-3","article-title":"Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution","volume":"13","author":"Stebounova","year":"2011","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0200","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0210","article-title":"Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation","volume":"4","author":"Chen","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0215","doi-asserted-by":"crossref","first-page":"1805097","DOI":"10.1002\/smll.201805097","article-title":"Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH","volume":"15","author":"Hajj","year":"2019","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0225","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1021\/acsnano.0c02358","article-title":"Polymer topology determines the formation of protein Corona on Core\u2013Shell nanoparticles","volume":"14","author":"Schroffenegger","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acsnano.7b05528","article-title":"The effects of biological fluids on colloidal stability and siRNA delivery of a pH-responsive micellar nanoparticle delivery system","volume":"12","author":"Malcolm","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0235","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1039\/C6RA25493D","article-title":"In vivo protein corona patterns of lipid nanoparticles","volume":"7","author":"Amici","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression \u2013 a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinformatics."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0245","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/acs.nanolett.5b03528","article-title":"An orthogonal Array optimization of lipid-like nanoparticles for mRNA delivery in vivo","volume":"15","author":"Li","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0250","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent Cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0255","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1002\/ange.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"124","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0260","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0265","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2015.09.002","article-title":"Personalized liposome\u2013protein corona in the blood of breast, gastric and pancreatic cancer patients","volume":"75","author":"Colapicchioni","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0270","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0275","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1726-4901(09)70389-2","article-title":"Potential function of amniotic fluid in fetal development\u2014novel insights by comparing the composition of human amniotic fluid with umbilical cord and maternal serum at mid and late gestation","volume":"72","author":"Tong","year":"2009","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0280","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0285","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0290","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.biocel.2015.11.005","article-title":"Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle\u2013cell interaction","volume":"75","author":"Gr\u00e4fe","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0295","doi-asserted-by":"crossref","first-page":"25879","DOI":"10.1038\/srep25879","article-title":"The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery","volume":"6","author":"Cardarelli","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0300","article-title":"Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides","volume":"23","author":"Wang","year":"2018","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.addr.2020.09.006","article-title":"Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy","volume":"160","author":"Figueroa-Espada","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0310","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2217\/nnm-2017-0178","article-title":"Plasma protein adsorption and biological identity of systemically administered nanoparticles","volume":"12","author":"Chen","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0315","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1074\/mcp.M700090-MCP200","article-title":"Proteomics analysis of human amniotic fluid *","volume":"6","author":"Cho","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jconrel.2021.10.031_bb0320","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/nano10030568","article-title":"In vivo biodistribution of respirable solid lipid nanoparticles surface-decorated with a mannose-based surfactant: a promising tool for pulmonary tuberculosis treatment?","volume":"10","author":"Truzzi","year":"2020","journal-title":"Nanomaterials."},{"key":"10.1016\/j.jconrel.2021.10.031_bb0325","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.7b00169","article-title":"Microencapsulated solid lipid nanoparticles as a hybrid platform for pulmonary antibiotic delivery","volume":"14","author":"Gaspar","year":"2017","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:20:51Z","timestamp":1759162851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921005848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":65,"alternative-id":["S0168365921005848"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}